Concepedia

Author

Regina Eickhoff

Philipps University of Marburg

Also Known As

R Eickhoff, R. Eickhoff, Regina Eickhoff

25

Publications

347

Citations

7

H-Index

24

Concepts

All Affiliations

Philipps University of MarburgJustus-Liebig-Universität Gießen
RE

About

Regina Eickhoff is an author at Philipps University of Marburg specializing in cell biology, immunology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

45

2

Cell Biology

2

2

45

3

Immunology

2

2

45

4

Public Health

1

1

17

5

Cellular Physiology

1

1

28

Regina Eickhoff

×

7

Publications

306

Citations

7

H-Index

YearCitations

Purification and Characterization of Macrophage Migration Inhibitory Factor as a Secretory Protein from Rat Epididymis: Evidences for Alternative Release and Transfer to Spermatozoa

Regina Eickhoff, Beate Wilhelm, Heiner Renneberg,

Molecular Medicine

2001

73

Influence of macrophage migration inhibitory factor (MIF) on the zinc content and redox state of protein-bound sulphydryl groups in rat sperm: indications for a new role of MIF in sperm maturation

Regina Eickhoff

Molecular Human Reproduction

2004

73

Ribosomal Protein S19 Interacts with Macrophage Migration Inhibitory Factor and Attenuates Its Pro-inflammatory Function

Ana-Maria Filip, Jörg Klug, Suada Fröhlich,

Journal of Biological Chemistry

2009

67

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

Michael Eichbaum, Christine Mayer, Regina Eickhoff,

BMC Cancer

2011

38

Macrophage migration inhibitory factor (MIF) as a paracrine mediator in the interaction of testicular somatic cells.

Andreas Meinhardt, Michael Bacher, Gunther Wennemuth,

PubMed

2000

28

Immunohistochemical Detection of Macrophage Migration Inhibitory Factor in Fetal and Adult Bovine Epididymis: Release by the Apocrine Secretion Mode?

Regina Eickhoff, G. Jennemann, G. Hoffbauer,

Cells Tissues Organs

2006

17

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology

S-E. Al-Batran, Daniel Mueller, M.-R. Rafiyan,

ESMO Open

2023

10

Page 1